Rossby Financial’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5K Buy
96
+5
+5% +$1.53K 0.01% 804
2026
Q1
$23K Sell
91
-231
-72% -$57.5K ﹤0.01% 958
2025
Q4
$88.6K Sell
322
-649
-67% -$178K 0.03% 428
2025
Q3
$264K Buy
971
+68
+8% +$16.5K 0.09% 229
2025
Q2
$198K Sell
903
-118
-12% -$25.2K 0.07% 260
2025
Q1
$219K Buy
+1,021
New +$281K 0.09% 207

Other funds holding WST

Rossby Financial's WST Position: Q2 2026 in Review

Rossby Financial increased its West Pharmaceutical (WST) stake by 5.5% in Q2 2026, buying an estimated $1.53K and bringing the position to 96 shares worth $34.5K. The position accounts for 0.01% of the portfolio, ranked #804.

Rossby Financial first reported a position in WST in Q1 2025 and has held it in 6 quarters since. The position peaked at $264K in Q3 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Rossby Financial held 96 shares of West Pharmaceutical worth $34.5K as of Q2 2026.
  • Rossby Financial bought 5 West Pharmaceutical shares in Q2 2026, an estimated $1.53K.
  • West Pharmaceutical made up 0.01% of Rossby Financial's portfolio in Q2 2026, its #804 holding.
  • Rossby Financial first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
  • Rossby Financial's West Pharmaceutical position peaked at $264K in Q3 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.